PA
AST

Parallel Advisors’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Parallel Advisors’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-200
Closed – – 2492
2018
Q4 		$0 Sell
200
-3,538
-95% -$3.67K ﹤0.01% 2444
2018
Q3 		$5K Hold
3,738
– – ﹤0.01% 1772
2018
Q2 		$5K Hold
3,738
– – ﹤0.01% 1639
2018
Q1 		$5K Buy
3,738
+200
+6% +$418 ﹤0.01% 1599
2017
Q4 		$8K Hold
3,538
– – ﹤0.01% 1409
2017
Q3 		$8K Hold
3,538
– – ﹤0.01% 1405
2017
Q2 		$13K Hold
3,538
– – ﹤0.01% 1229
2017
Q1 		$11K Hold
3,538
– – ﹤0.01% 1211
2016
Q4 		$16K Buy
+3,538
New +$14.6K ﹤0.01% 961

Parallel Advisors's AST Position: Q1 2019 in Review

Parallel Advisors sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 200 shares.

Parallel Advisors first reported a position in AST in Q4 2016 and held it in 9 quarters. The position peaked at $16K in Q4 2016. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Parallel Advisors reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Parallel Advisors sold 200 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
  • Parallel Advisors first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2016 and held it in 9 quarters.
  • Parallel Advisors's Asterias Biotherapeutics Inc. Series A position peaked at $16K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Parallel Advisors's 13F filing for Q1 2019, filed 1 May 2019.